The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).
 
Anna Skakodub
No Relationships to Disclose
 
Kathryn Ries Tringale
No Relationships to Disclose
 
Henry S. Walch
No Relationships to Disclose
 
Harish Vasudevan
Stock and Other Ownership Interests - Genentech
 
Jordan Eichholz
No Relationships to Disclose
 
Daniel W. Kelly
No Relationships to Disclose
 
Nelson S. Moss
Consulting or Advisory Role - AstraZeneca
Research Funding - GT Medical Technologies (Inst)
 
Kenny Kwok Hei Yu
No Relationships to Disclose
 
Bob T. Li
Research Funding - Ambrx (Inst); Amgen (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Daiichi Sankyo (Inst); Hengrui Therapeutics (Inst); Lilly (Inst); MORE Health (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Karger Publishers - Book royalty; Shanghai Jiao Tong University Press - Book royalty; US62/514,661 (Inst); US62/685,057 (Inst)
Travel, Accommodations, Expenses - Jiangsu Hengrui Medicine; MORE Health
(OPTIONAL) Uncompensated Relationships - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Genentech; Lilly
 
Boris Mueller
No Relationships to Disclose
 
Jonathan T. Yang
Stock and Other Ownership Interests - Nanocan Therapeutics
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Galera Therapeutics; Nanocan Therapeutics
Research Funding - AstraZeneca; Kazia Therapeutics; X-RAD Therapeutics
 
Kathryn Beal
Stock and Other Ownership Interests - MMT; MMT (I)
 
Brandon S. Imber
Honoraria - GT Medical Technologies
 
Daniel Richard Gomez
Honoraria - AstraZeneca/Merck; Bristol-Myers Squibb; Merck; Reflexion Medical; US Oncology; Varian Medical Systems; Vindico
Consulting or Advisory Role - Olympus Medical Systems
Research Funding - AstraZeneca/Merck; Bristol-Myers Squibb; Varian Medical Systems
Travel, Accommodations, Expenses - AstraZeneca/Merck; US Oncology; Varian Medical Systems; Vindico
 
Nikolaus Schultz
No Relationships to Disclose
 
Luke Roy George Pike
Stock and Other Ownership Interests - Clovis Oncology; Novavax; Schrodinger
Consulting or Advisory Role - Aviko; Best Doctors, Inc; Blackstone; Deerfield Management; Dynamo Therapeutics; Galera Therapeutics; Monograph Capital; Myst Therapeutics; Roivant; Third Rock Ventures; Turnstone Bio